Selected Publications

On, A., Caussade, MC., Britt, A., Sheppard, S., Adams, D., Stockton Hogrogian, G., Treat, J.: : Visualizing Genetics: An investigation of dermoscopy as a tool for genetic variant prediction in capillary malformations. Pediatric Dermatology October 2025.

Mack, J., Crary, S., Blatt, J., Spray, B., Borst, A., Ruiz-Gutierrez, M., Kreimer, S., Iacobas, I., Swaminathan, N., Tran, A., Adams, D., Jeng, M: Impact of Anticoagulation on Quality of Life in Patients with Slow-Flow Vascular Malformations. Blood Vessels, Thrombosis & Hemostasis September 2025.

Michael Kelly, Denise Adams, Francine Blei: Chapter 454: Vascular neoplasms. Rudolph’s Pediatrics, 24th Edition September 2025.

Fox, M., Kumar, S., Britt, A., Srinivasan, A., Surrey, L., Vatsky, S., Borst, J., Hakonarson, H., Li, D., Sheppard, S., Snyder, K., Adams, D: Expansion of the phenotype of lymphatic anomalies caused by somatic activating BRAF variant. Pediatric Blood & Cancer August 2025.

Torales, L.D.G., Woodis, K., Britt, A., Surrey, L., Srinivasan, A., Ganguly, A., Limmina, M., Li, D., MacFarland, S., Adams, D., Sheppard, S.: Multiple genetic technologies validate rare novel variant and direct medical care in vascular anomalies. American Journal of Medical Genetics. July 2025.

102. Pirov, E., Kleinman, E., Elizarov, E., Rodrigues, M., Baum, A., Blei, F., Adams, D., Greenberger, S.: Beta-blockers efficacy and safety in the treatment of PHACE syndrome: A systematic review. Journal of the European Academy of Dermatology and Venereology July 2025.

Berna, R., Hasbun, T., Adams, D., Moon, A. T., & Treat, J. R: Significant improvement of a nevus spilus-type congenital melanocytic nevus with oral selumetinib. Pediatric Dermatology June 2024.

Alexandra J. Borst, Allison Britt, Denise M Adams: Complex lymphatic anomalies: Molecular landscape and medical management. Seminars in pediatric surgery June 2024.

Patricia Patura, C. Griffin McDaniel, Sara Alharbi, Dermot Fox, Bethany Coleman, Punman Malik, Denise M. Adams, Timothy D. Le Cras: NRASQ61R mutation drives elevated angiopoietin-2 expression in human endothelial cells and a genetic mouse model. Pediatric Blood & Cancer May 2024.

94. Guillaume Canaud, Lola Zerbib, Sophia Ladraa, Antoine Fraissenon, Charles Bayard, Marina Firpion, Quitterie Venot, Sanela Protic, Clement Hoguin, Amandine Thomas, Sylvie Fraitag, Jean Paul Duong, Sophie Kaltenbach, Patrick Villarese, Vahid Asnafi, Christine Broissand, Nicolas Goudin, Ivan Nemazanyy, Gwennhael Autret, Bertrand Tavitian, Christophe Legendre, Nadia Arzouk, Veronique Minard-Colin, Caroline Chopinet, Michael Dussiot, Denise Adams, Laurent Guibaud, Paul Isenring, Estelle Balducci, Coline Lefevre, and Tristan Mirault: Targeted therapy for capillary-venous malformations. Signal Transduction and Targeted Therapy April 2024.